Skip to main content Accessibility help

Dexamethasone Suppression Test in Dementia and Depression: Clinical and Biological Correlates

  • J. Shrimankar (a1), Som D. Soni (a2) and J. McMurray (a3)


To determine the usefulness of the DST in differentiating depression from dementia, the test was administered to three diagnostic groups of psychogeriatric patients: depression; dementia; and dementia with depression. Clinical assessments were supplemented by ratings on the HRSD and SCAG, as well as by EEG and CT. All three groups showed a high incidence of abnormal DST results unrelated to presence or severity of affective symptoms, but showing a better association with SCAG and its ‘organic’ subsets. The mechanism(s) underlying these abnormal results may reflect organic brain disease. The usefulness of the DST in differentiating depression from dementia in the elderly was not confirmed.


Corresponding author



Hide All
Abou-Saleh, M. T., Spalding, E. M., Kellett, J. M., et al (1987) Dexamethasone suppression test in dementia. International Journal of Geriatric Psychiatry, 2, 5965.
American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (3rd edn) (DSM-III). Washington, DC: APA.
Balldin, J., Gottfries, C., Karlsson, I., et al (1983) Dexamethasone suppression test and serum prolactin in dementia disorders. British Journal of Psychiatry, 143, 277281.
Beckett, G. J., Gray, S. M. & Seth, J. (1982) In Immunoassays for Clinical Chemistry (2nd edn) (eds Hunter, W. M. & Corrie, J. E. T.) pp. 201202. London: Churchill Livingstone.
Berger, M., Pirkie, K.-M., Doerr, P., et al (1984) The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry. British Journal of Psychiatry, 145, 372382.
Bondareff, W., Mountjoy, C. Q. & Roth, M. (1981) Selective loss of neurones of origin of adrenergic projection to the cerebral cortex (nucleus locus coerulus) in senile dementia. Lancet, i, 783784.
Bowen, D. M., White, P., Falck, R. H. A., et al (1974) Brain-decarboxylase activities as indices of pathological change in senile dementia. Lancet, i, 12471249.
Bowen, D. M., Smith, C. B., White, P., et al (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain, 99, 459496.
Branconnier, R. J., Oxenkrug, G. F., McIntyre, L., et al (1984) Prediction of serum cortisol response to dexamethasone in normal volunteers: a multivariate approach. Psychopharmacology, 84, 274275.
Carnes, M., Smith, J. C., Kalin, N. H., et al (1983) Effects of chronic medical illness and dementia on the dexamethasone suppression test. Journal of American Geriatric Society, 31, 267 271.
Carroll, B. J. (1982) The dexamethasone suppression test for melancholia. British Journal of Psychiatry, 140, 292304.
Carroll, B. J., Feinberg, M., Greden, J. F., et al (1981) A specific laboratory test for the diagnosis of melancholia. Standardisation, validation and clinical utility. Archives of General Psychiatry, 38, 1522.
Coppen, A., Abou-Saleh, P., Milln, P., et al (1983) Does dexamethasone suppression test predict antidepressant treatment success? British Journal of Psychiatry, 142, 498504.
Dilman, V. M., Lapin, I. P. & Oxenkrug, G. F. (1979) Serotonin and ageing. In Serotonin in Health and Disease (ed. Essman, W. B.). New York: Spectrum Publications.
Folstein, M. F. & McHugh, P. R. (1978) Dementia syndrome of depression. In Alzheimer's Disease, Senile Dementia and Related Disorders (eds Katzman, R., Terry, R. D. & Bick, K. L.). New York: Raven Press.
Georgotas, A., McCue, R. E., Kim, M., et al (1986) Dexamethasone suppression test in dementia, depression and normal ageing. American Journal of Psychiatry, 143, 452456.
Greenwald, B. S., Mathe, A. A., Mohs, R. C., et al (1986) Cortisol and Alzheimer's disease. II: Dexamethasone suppression, dementia severity and affective symptoms. American Journal of Psychiatry, 143, 442446.
Hamilton, M. (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278296.
Katona, C. L. E. & Aldridge, C. R. (1985) The dexamethasone suppression test and depressive signs in dementia. Journal of Affective Disorders, 8, 8389.
Mann, D. M. A., Lincoln, J., Yates, P. O., et al (1980) Changes in monoamine containing neurones of the human CNS in senile dementia. British Journal of Psychiatry, 136, 533541.
Mann, D. M. A. & Yates, P. O. (1983) Serotonin nerve cells in Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry, 46, 96.
Mann, D. M. A., Yates, P. O., & Marcyniuk, B. (1985) Some morphometry observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age. Journal of Neurological Science, 69, 139159.
Marsden, C. D. & Harrison, M. J. G. (1972) Outcome of investigation of patients with presenile dementia. British Medical Journal, ii, 249252.
McAllister, T. W., Ferrell, R. B., Price, T. R. P., et al (1982) The dexamethasone suppression test in two patients with severe depressive pseudodementia. American Journal of Psychiatry, 139, 479481.
McKeith, I. G. (1984) Clinical use of the DST in a psychogeriatric population. British Journal of Psychiatry, 145, 389393.
Nott, P. N. & Fleminger, J. J. (1975) Presenile dementia: the difficulties of early diagnosis. Acta Psychiatrica Scandinavica, 51, 210217.
O'Neal, P., Robins, E. & Schmidt, E. H. (1956) A psychiatric study of attempted suicide in persons over sixty years of age. Archives of Neurologie and Psychiatry, 75, 275.
Oxenkrug, G. F., Pomara, N., McIntyre, L., et al (1983) Ageing and cortisol resistance to suppression by dexamethasone: a positive correlation. Psychiatry Research, 10, 125130.
Pearson, R. C. A., Esiri, M. M., Hirons, R. W., et al (1985) Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. Proceedings of the National Academy of Sciences, USA, 82, 45314534.
Perry, E. K., Perry, R. H., Blessed, G., et al (1977) Necropsy evidence of central cholinergic deficits in senile dementia. Lancet, i, 189.
Post, F. (1962) The Significance of Affective Symptoms in Old Age. London: Oxford University Press.
Post, F. (1975) Dementia, depression and pseudodementia. In Psychiatric Aspects of Neurologic Disease (eds Benson, D. F. & Blumer, D.). New York: Grune and Stratton.
Raskind, M., Peskind, E., Rivard, M. F., et al (1982) Dexamethasone suppression test and cortisol rhythms in primary degenerative dementia. American Journal of Psychiatry, 139, 14681471.
Reisine, T. D., Yamamura, H. I., Bird, E. D. et al (1978) Pre- $and post-synaptic neurochemical alterations in Alzheimer's disease. Brain Research, 159, 477481.
Rudorfer, M. V. & Clayton, P. J. (1982) Pseudodementia – use of the DST in diagnosis and treatment monitoring. Psychosomatics, 23, 429431.
Sim, M. (1985) Alzheimer's disease: a forgotten entity. Geriatrics, 20, 668674.
Shader, R. I. (1974) A new scale for clinical assessment in geriatric populations: Sandoz Clinical Assessment – Geriatric (SCAG). Journal of the American Geriatric Society, 22, 107113.
Shrimankar, J., Soni, S. D. & Sampath, G. (1988) Dexamethasone suppression test and response to antidepressant therapy in psychogeriatric patients. Acta Psychiatrica Scandinavica, 77, 712718.
Slater, E. & Roth, M. (1969) Clinical Psychiatry, p. 9. London: Bailliere Tindall.
Spar, J. E. & Gerner, R. (1982) Does dexamethasone suppression test distinguish dementia from depression? American Journal of Psychiatry, 139, 238240.
Sulkava, R., Haltia, M., Paetau, A., et al (1983) Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings. Journal of Neurology, Neurosurgery and Psychiatry, 46, 913.
Tourigny-Rivard, M. F., Raskind, M. & Rivard, D. (1981) The dexamethasone suppression test in an elderly population. Biological Psychiatry, 16, 11771184.
Venn, R. D. (1983) The Sandoz Clinical Assessment – Geriatric (SCAG) scale. A general purpose psychogeriatric rating scale. Gerontology, 29, 185198.
Wells, C. E. (1979) Pseudodementia. American Journal of Psychiatry, 136, 895900.
Yates, C., Ritchie, E., Simpson, J., et al (1981) Noradrenaline in Alzheimer-type dementia and Down syndrome. Lancet, ii, 3940.

Dexamethasone Suppression Test in Dementia and Depression: Clinical and Biological Correlates

  • J. Shrimankar (a1), Som D. Soni (a2) and J. McMurray (a3)


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Dexamethasone Suppression Test in Dementia and Depression: Clinical and Biological Correlates

  • J. Shrimankar (a1), Som D. Soni (a2) and J. McMurray (a3)
Submit a response


We encountered an error trying to retrieve eLetters for this article. Please try again or contact Customer Services


Reply to: Submit a response

Your details

Conflicting interests

Do you have any conflicting interests? *